Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,199 total articles
Edward T. Mathers, a 10% holder of Korro Bio, acquired 207,100 shares of the company's common stock and 242,945 pre-funded warrants on March 10, 2026, spending roughly $2.3 million on the common shares. The transaction precedes a scheduled earnings report and follows an $85 million private investment in public equity financing and a series of analy…
Mohamad Makhzoumi, who holds a roughly 10% stake in Korro Bio, bought 207,100 shares at $11.11 each on March 10, 2026, a transaction valued at $2,300,881. The purchase was filed on a Form 4 with the SEC. Makhzoumi also acquired 242,945 Pre-Funded Warrants at $11.109 and now indirectly owns 1,297,893 Korro Bio shares. The company has announced a pri…
Sera Prognostics Chief Information Officer Harrison Robert Gardner sold 716 Class A shares on March 11, 2026, for $2.04 each, netting $1,460 to meet tax obligations tied to vested restricted stock units. The transaction was executed as a block trade across prices of $1.90 to $2.30. The stock trades near $1.99 and has fallen 51% over the past year. …
Benjamin Jackson, general counsel of Sera Prognostics, sold 1,027 shares of the company's Class A common stock on March 11, 2026, in a transaction that generated roughly $2,095. The sale, disclosed on a Form 4 filing, was described as a means to satisfy tax withholding tied to the vesting of restricted stock units. The move comes amid positive clin…
Sera Prognostics Chief Scientific Officer John J. Boniface sold 1,517 shares of Class A common stock on March 11, 2026, to satisfy tax withholding related to vested restricted stock units. The trade amounted to roughly $3,094 at a weighted average price of $2.04. The company has recently reported strong clinical-trial data for its PreTRM test and r…
Rapid Micro Biosystems Chief Financial Officer Sean M. Wirtjes sold 7,480 shares on March 11, 2026, at $4.3181 per share to satisfy tax obligations tied to vested restricted stock units. The disposition totaled roughly $32,299 and leaves Wirtjes with 556,194 shares. The stock is trading below the sale price amid recent short-term weakness, and the …
Rapid Micro Biosystems Chief Operating Officer John J. Addington Wilson sold 9,603 Class A shares on March 11, 2026, in a transaction totaling $41,466 to cover tax obligations tied to restricted stock vesting. The sale was disclosed on a Form 4 filing with the SEC. The company recently reported Q4 2025 revenue of $11.3 million, beating analyst expe…
Scott Michael Fitzgerald, Principal Accounting Officer at StubHub Holdings Inc (NASDAQ: STUB), sold 28,387 shares of Class A common stock on March 11, 2026, for roughly $217,546. The sale, executed under a Rule 10b5-1 plan, occurred as the stock traded close to its 52-week low and followed disappointing fourth-quarter results and several analyst ad…
Arlo Technologies Chief Financial Officer Kurtis Joseph Binder executed an insider sale of 179,419 shares on March 12, 2026, for roughly $2.47 million, after exercising 333,334 Performance Stock Units on March 10, 2026. The transactions leave Binder with direct ownership of 614,885 shares. The moves come as Arlo reported better-than-expected fourth…
Arlo Technologies General Counsel Brian Busse sold 25,525 shares on March 12, 2026 for roughly $351,609 at an average price of $13.7751 after converting 50,000 performance stock units into common shares on March 10, 2026. The company reported better-than-expected Q4 2025 results and its board approved a share buyback program of up to $50 million th…
Engert Oliver, chief administrative officer of Enovis CORP, purchased 1,000 shares of the company’s common stock on March 10, 2026, paying a weighted average between $23.75 and $24.10 for a total of $23,930. The transaction increases his direct holdings to 47,640 shares amid mixed fourth-quarter results and guidance that diverges from consensus est…
Kelley Stephen Douglas, President and CEO of Advanced Energy Industries Inc, sold 45,551 shares on March 10, 2026 under a prearranged 10b5-1 trading plan, generating $15.83 million. The sale occurred as AEIS shares have risen materially over the past year and after the company reported quarterly results that topped forecasts and prompted analyst ta…
Intuit director Richard L. Dalzell disposed of 999 shares of the company's common stock over three trading days in March 2026, generating proceeds of $457,045. The trades were carried out under a Rule 10b5-1 plan adopted in March 2025. The transactions coincided with recent volatility in Intuit shares and a quarter of solid financial performance, w…
Isto Mark, a director at Royal Gold Inc. (NASDAQ: RGLD), sold 2,000 shares on March 12, 2026, for $274.83 each, totaling $549,660. The transaction follows a 77.6% one-year gain in the stock, which trades at a price-to-earnings ratio of 40.68. Royal Gold reported mixed fourth-quarter 2025 results - revenue topped expectations while EPS fell short - …
Slide Insurance Holdings Inc. (NASDAQ: SLDE) President and COO Shannon Lucas sold 11,970 shares on March 10 and 11, 2026, for approximately $212,963. The transactions took place while the stock declined about 11% over the prior seven days. The company reported stronger-than-expected fourth-quarter 2025 results and received an increased price target…
SmartRent director Thomas N. Bohjalian acquired 150,000 shares of Class A common stock on March 12, 2026, for $260,490. The purchase, at a weighted average price of $1.7366 per share, brings his direct holdings to 500,000 shares. The transaction coincides with recent fourth-quarter 2025 results that slightly exceeded expectations and a revised valu…
Regenxbio Chief Medical Officer Steve Pakola sold 5,124 shares of company stock on March 10, 2026, under a Rule 10b5-1 trading plan for $10.35 per share, totaling $53,033. The company reported encouraging interim Phase I/II AFFINITY DUCHENNE data for RGX-202 and disclosed 2025 financial results showing revenue of $170.4 million and a full-year net …
Venture Global SVP and Chief Accounting Officer Blake Sarah sold 119,300 shares of the company’s Class A common stock on March 12, 2026, receiving $1,551,842. The transaction followed an exercise of options to acquire the same number of shares at $1.55 apiece. The company reported a Q4 2025 earnings shortfall even as revenue climbed sharply, and re…
Patrick Kirscht, Chief Credit Officer at Oportun Financial Corp (OPRT), sold 54,300 shares on March 10, 2026, for roughly $266,065, according to a Form 4 filing. The sale prices ranged from $4.805 to $4.995 and were executed at an average reported price of $4.90 per share. The company recently reported fourth-quarter 2025 results featuring a revenu…
Control Empresarial de Capitales S.A. de C.V., a roughly ten percent owner of PBF Energy Inc., sold 860,000 shares of the company's Class A common stock across two trades on March 10 and March 11, 2026, raising $36,005,619. After the transactions the investor holds 25,391,098 shares. The trades took place as PBF shares traded at $42.92 following a …
NMI Holdings Executive Chairman Bradley M. Shuster sold 18,976 shares on March 12, 2026, for about $694,147 and exercised options to acquire 55,158 shares. The firm reported Q4 2025 results that topped expectations, while market metrics point to a low P/E valuation of 7.55 according to InvestingPro analysis.
Privia Health Group Chief Executive Officer Parth Mehrotra sold 21,097 shares of company common stock on March 10, 2026, for roughly $479,112 under a pre-arranged Rule 10b5-1 plan. The filings show simultaneous equity grants in the form of restricted stock units and performance stock units, and the company recently reported fourth-quarter 2025 resu…
Thimaya K. Subaiya, Executive Vice President of Operations at Cisco Systems, sold 1,744 shares of company stock on March 12, 2026, under a previously established Rule 10b5-1 plan. The transaction, executed at $77.07 per share for $134,410, follows a March 10, 2026 withholding of 1,715.468 shares to cover tax obligations. These moves come as Cisco r…
Ken Vroman, Chief Transformation Officer at CME Group, sold 5,160 shares of Class A common stock on March 12, 2026, for roughly $1.59 million. The transaction occurred as CME stock traded near a 52-week high and follows company announcements of record open interest in U.S. Treasury futures, plans for 24/7 cryptocurrency trading pending approval, ex…
Matson Senior Vice President Christopher A. Scott reported a sale of 2,509 shares on March 11, 2026, generating $388,895 in proceeds. The transaction leaves Scott with 14,533.4890 shares. The move comes amid Matson's better-than-expected fourth-quarter results, robust China service demand, and an announced executive retirement.
